- Home
- GALT vs SNCR Comparison
GALT vs SNCR Comparison
Compare GALT & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- SNCR
- Stock Information
- Founded
- GALT 2000
- SNCR 2000
- Country
- GALT United States
- SNCR United States
- Employees
- GALT N/A
- SNCR N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- SNCR EDP Services
- Sector
- GALT Health Care
- SNCR Technology
- Exchange
- GALT Nasdaq
- SNCR Nasdaq
- Market Cap
- GALT 83.5M
- SNCR 79.2M
- IPO Year
- GALT N/A
- SNCR 2006
- Fundamental
- Price
- GALT $2.60
- SNCR $6.39
- Analyst Decision
- GALT Buy
- SNCR Strong Buy
- Analyst Count
- GALT 2
- SNCR 1
- Target Price
- GALT $6.00
- SNCR $13.00
- AVG Volume (30 Days)
- GALT 1.2M
- SNCR 72.1K
- Earning Date
- GALT 08-12-2025
- SNCR 08-05-2025
- Dividend Yield
- GALT N/A
- SNCR N/A
- EPS Growth
- GALT N/A
- SNCR N/A
- EPS
- GALT N/A
- SNCR N/A
- Revenue
- GALT N/A
- SNCR $172,842,000.00
- Revenue This Year
- GALT N/A
- SNCR $2.07
- Revenue Next Year
- GALT N/A
- SNCR $5.42
- P/E Ratio
- GALT N/A
- SNCR N/A
- Revenue Growth
- GALT N/A
- SNCR 4.64
- 52 Week Low
- GALT $0.73
- SNCR $6.21
- 52 Week High
- GALT $3.90
- SNCR $15.46
- Technical
- Relative Strength Index (RSI)
- GALT 70.66
- SNCR 33.11
- Support Level
- GALT $1.28
- SNCR $6.60
- Resistance Level
- GALT $1.36
- SNCR $7.26
- Average True Range (ATR)
- GALT 0.33
- SNCR 0.40
- MACD
- GALT 0.18
- SNCR 0.05
- Stochastic Oscillator
- GALT 52.40
- SNCR 14.75
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About SNCR Synchronoss Technologies Inc.
Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.